Ovarian stimulation is applied during infertility management either alone or in conjunction
with intrauterine insemination and assisted reproductive technologies. At the present time …

Ovarian stimulation during infertility treatment is used either alone or in conjunction with
intrauterine insemination and assisted reproductive technologies. At the present time, the …

The selective estrogen receptor modulator, clomiphene citrate (CC), has been the principal
drug used for induction of ovulation in women with polycystic ovarian syndrome (PCOS). CC …

Context: Anovulation is likely responsible for 20% of female infertility. Although clomiphene
citrate remains the first-line therapy for ovulation induction in anovulatory patients who are …

OBJECTIVE: This study was undertaken to report the outcome of pregnancies achieved after
ovarian stimulation, including the use of the aromatase inhibitor, letrozole, for ovarian …

This prospective randomized pilot study was aimed at investigating the effect of the novel
addition of aromatase inhibitors to an ovarian stimulation protocol for IVF or intracytoplasmic …

BACKGROUND Impaired fertility is thought to affect 10 to 15% of couples but this
percentage may be an underestimate [1][2] because the inability to conceive carries a …

Clinical utilization of ovulation stimulation to facilitate the ability of a couple to conceive has
not only provided a valuable therapeutic approach, but has also yielded extensive …

For almost half a century, the first-line treatment for ovulation induction in cases of
anovulation, unexplained infertility, or mild male factor has been clomifene (clomiphene …

Ovulation induction remains a milestone in the treatment of women with anovulatory
infertility. Clomiphene citrate (CC) is considered the first line treatment for induction of …